Products of Conception

  • 3E0E Products of Conception
    • 3E0E3 Percutaneous
      • 3E0E30 Antineoplastic
        • 3E0E304 Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach
        • 3E0E305 Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach
        • 3E0E30M Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach
      • 3E0E32 Anti-infective
        • 3E0E328 Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach
        • 3E0E329 Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach
      • 3E0E33 Anti-inflammatory
        • 3E0E33Z Introduction of Anti-inflammatory into Products of Conception, Percutaneous Approach
      • 3E0E36 Nutritional Substance
        • 3E0E36Z Introduction of Nutritional Substance into Products of Conception, Percutaneous Approach
      • 3E0E37 Electrolytic and Water Balance Substance
        • 3E0E37Z Introduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach
      • 3E0E3B Anesthetic Agent
        • 3E0E3BZ Introduction of Anesthetic Agent into Products of Conception, Percutaneous Approach
      • 3E0E3G Other Therapeutic Substance
        • 3E0E3GC Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach
      • 3E0E3H Radioactive Substance
        • 3E0E3HZ Introduction of Radioactive Substance into Products of Conception, Percutaneous Approach
      • 3E0E3K Other Diagnostic Substance
        • 3E0E3KZ Introduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach
      • 3E0E3N Analgesics, Hypnotics, Sedatives
        • 3E0E3NZ Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach
      • 3E0E3S Gas
        • 3E0E3SF Introduction of Other Gas into Products of Conception, Percutaneous Approach
      • 3E0E3T Destructive Agent
        • 3E0E3TZ Introduction of Destructive Agent into Products of Conception, Percutaneous Approach
    • 3E0E4 Percutaneous Endoscopic
      • 3E0E4G Other Therapeutic Substance
        • 3E0E4GC Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach
    • 3E0E7 Via Natural or Artificial Opening
      • 3E0E70 Antineoplastic
        • 3E0E704 Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening
        • 3E0E705 Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening
        • 3E0E70M Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening
      • 3E0E72 Anti-infective
        • 3E0E728 Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening
        • 3E0E729 Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening
      • 3E0E73 Anti-inflammatory
        • 3E0E73Z Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening
      • 3E0E76 Nutritional Substance
        • 3E0E76Z Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening
      • 3E0E77 Electrolytic and Water Balance Substance
        • 3E0E77Z Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening
      • 3E0E7B Anesthetic Agent
        • 3E0E7BZ Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening
      • 3E0E7G Other Therapeutic Substance
        • 3E0E7GC Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening
      • 3E0E7H Radioactive Substance
        • 3E0E7HZ Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening
      • 3E0E7K Other Diagnostic Substance
        • 3E0E7KZ Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening
      • 3E0E7N Analgesics, Hypnotics, Sedatives
        • 3E0E7NZ Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening
      • 3E0E7S Gas
        • 3E0E7SF Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening
      • 3E0E7T Destructive Agent
        • 3E0E7TZ Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening
    • 3E0E8 Via Natural or Artificial Opening Endoscopic
      • 3E0E80 Antineoplastic
        • 3E0E804 Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic
        • 3E0E805 Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic
        • 3E0E80M Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E82 Anti-infective
        • 3E0E828 Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic
        • 3E0E829 Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E83 Anti-inflammatory
        • 3E0E83Z Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E86 Nutritional Substance
        • 3E0E86Z Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E87 Electrolytic and Water Balance Substance
        • 3E0E87Z Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E8B Anesthetic Agent
        • 3E0E8BZ Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E8G Other Therapeutic Substance
        • 3E0E8GC Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E8H Radioactive Substance
        • 3E0E8HZ Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E8K Other Diagnostic Substance
        • 3E0E8KZ Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E8N Analgesics, Hypnotics, Sedatives
        • 3E0E8NZ Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E8S Gas
        • 3E0E8SF Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic
      • 3E0E8T Destructive Agent
        • 3E0E8TZ Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic